HEMATOLOGICAL MALIGNANCY
Clinical trials for HEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood 'Photo' therapy may stop transplant rejection
Disease control CompletedThis study tested whether a procedure called extracorporeal photopheresis (ECP) could prevent graft-versus-host disease (GVHD) in 158 patients receiving stem cell transplants for blood cancers. ECP involves removing white blood cells, treating them with a light-sensitive drug and…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: NA • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 23, 2026 19:34 UTC
-
Fish oil may ease side effects of stem cell transplants in kids
Disease control CompletedThis early-stage trial tested whether a fish oil-based fat emulsion is safe and tolerable for 20 children undergoing stem cell transplants for cancer or blood disorders. The fish oil emulsion was compared to the standard soybean oil emulsion. The goal was to see if the omega-3-ri…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE1 • Sponsor: Alexandra N. Carey • Aim: Disease control
Last updated Jun 22, 2026 11:55 UTC
-
New melphalan combo shows promise in Half-Matched transplants for blood cancer patients
Disease control CompletedThis study tested a new version of the chemotherapy drug melphalan (EVOMELA) combined with fludarabine and total body irradiation before a half-matched (haploidentical) stem cell transplant in 43 adults with blood cancers like multiple myeloma. The goal was to see if this approac…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Immune booster after transplant shows promise for blood cancer patients
Disease control CompletedThis early-phase study tested whether giving specially selected donor immune cells (NK cells) soon after a stem cell transplant is safe for people with blood cancers. Seventeen patients received the cells, and researchers monitored for serious side effects within 30 days. The goa…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE1 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 02, 2026 11:58 UTC
-
New program helps caregivers of stem cell patients cope better
Symptom relief CompletedThis study tested a support program for people caring for a loved one undergoing a stem cell transplant for blood cancer. The program included 8 online sessions over 12 weeks to teach stress management, coping skills, and communication. 17 caregivers took part, and the study chec…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 18, 2026 11:52 UTC